Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

11.1%

2 terminated/withdrawn out of 18 trials

Success Rate

88.2%

+1.7% vs industry average

Late-Stage Pipeline

83%

15 trials in Phase 3/4

Results Transparency

107%

16 of 15 completed trials have results

Key Signals

16 with results

Enrollment Performance

Analytics

Phase 4
15(83.3%)
Phase 2
3(16.7%)
18Total
Phase 4(15)
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT05253755Phase 2Terminated

Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel

Role: collaborator

NCT04555525Phase 4Completed

A Pilot Study on the Use of Seysara for Rosacea

Role: lead

NCT04555707Phase 4Unknown

The Maintenance Effect of Enstilar Foam in Combination With Otezla

Role: lead

NCT03848871Phase 4Completed

The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients

Role: lead

NCT02871479Phase 2Completed

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis

Role: collaborator

NCT03000608Phase 2Completed

A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis

Role: collaborator

NCT03457636Phase 4Completed

The Use of Oracea and Epiduo Forte in Severe Acne Patients

Role: lead

NCT02944461Phase 4Completed

Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

Role: lead

NCT03402893Phase 4Completed

The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color

Role: lead

NCT03000309Phase 4Completed

Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy

Role: lead

NCT01064947Phase 4Completed

Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis

Role: lead

NCT02147691Phase 4Completed

Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study

Role: lead

NCT01885910Phase 4Completed

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

Role: lead

NCT00884325Phase 4Completed

Management of Pruritus With Xyzal in Atopic Dermatitis

Role: lead

NCT01065714Phase 4Completed

A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis

Role: lead

NCT01038869Phase 4Completed

Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)

Role: lead

NCT00608777Phase 4Terminated

Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)

Role: lead

NCT00302445Phase 4Completed

A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis

Role: lead

All 18 trials loaded